Africa's First Multi-Vaccine Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: South Africa
Source: Mapepeza News
Biovac is building Africa's first end-to-end multi-vaccine manufacturing facility in South Africa to strengthen health security, expand vaccine manufacturing capacity, and improve access to essential immunisations. The facility will initially produce oral cholera vaccines and later expand to polio, pneumonia, and meningitis vaccines, with an expected annual output of 30 to 40 million doses.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Biovac is building Africa's first end-to-end multi-vaccine manufacturing facility in South Africa to strengthen health security, expand vaccine manufacturing capacity, and improve access to essential immunisations. The facility will initially produce oral cholera vaccines and later expand to polio, pneumonia, and meningitis vaccines, with an expected annual output of 30 to 40 million doses. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |